← Back to Search

Behavioural Intervention

Active and Sham Audiovisual Stimulation (Mild AD): for Healthy Aging (CAD Trial)

N/A

Recruiting

Research Sponsored by Clarity Health Technologies, Inc

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Mild AD Participants: A diagnosis of mild Alzheimer's disease

Mild AD Participants: Normal or corrected to normal vision

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately after the intervention

Awards & highlights

CAD Trial Summary

This trial will test whether it is safe and comfortable to use Virtual Reality headsets to provide audiovisual stimulation to people with mild Alzheimer's disease and healthy individuals of the same age.

Who is the study for?

This trial is for individuals with mild Alzheimer's disease and healthy older adults. Specific criteria aren't provided, but typically participants must meet certain health standards and not have conditions that could interfere with the study or pose a risk.Check my eligibility

What is being tested?

The study tests if it's safe and feasible to use a VR headset to provide audiovisual stimulation to people with mild Alzheimer's and healthy aging individuals. It’s single-blind, meaning only the participants won’t know if they’re getting the real treatment or a sham (fake) version.See study design

What are the potential side effects?

Since this trial focuses on safety and tolerability, potential side effects might include discomfort from wearing the VR headset, dizziness, nausea, eye strain or emotional reactions to the stimuli.

CAD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with mild Alzheimer's disease.

Select...

My vision is normal or corrected to normal.

Select...

I am between 50 and 90 years old and have no cognitive impairments.

Select...

I have mild Alzheimer's and my hearing is normal.

CAD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in brain activity associated with exposure to VR-based audiovisual stimulation

Incidence of Stimulation-Emergent Adverse Events

Level of tolerance to VR-based sensory stimulation exposure

CAD Trial Design

2Treatment groups

Experimental Treatment

Group I: Active and Sham Audiovisual Stimulation (Mild AD):Experimental Treatment1 Intervention

Both active and sham stimulation conditions will be delivered to 30 participants with Mild AD to demonstrate the mechanism of action of the intervention.

Group II: Active and Sham Audiovisual Stimulation (Cognitively Normal):Experimental Treatment1 Intervention

Both active and sham stimulation conditions will be delivered to 30 cognitively normal participants to demonstrate the mechanism of action of the intervention.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Clarity Health Technologies, IncLead Sponsor

SymmetryScience Group, Inc.Industry Sponsor

1 Previous Clinical Trials

88 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals being enrolled in this research project?

"Indeed, the information provided on clinicaltrials.gov affirms that this investigation is currently in search of eligible participants. The study was initially published on December 14th, 2023 and underwent its most recent update on January 22nd, 2024. To complete the trial, a total of 60 patients will be enrolled from a single designated site."

Answered by AI

Is the trial open to individuals aged 85 and above for potential participation?

"Individuals aged 50 and above, but below the age of 90, are eligible for inclusion in this research study."

Answered by AI

What are the eligibility criteria for individuals seeking to participate in this clinical study?

"To be deemed eligible for this study, individuals must exhibit successful aging and fall within the age range of 50 to 90 years. Approximately 60 participants will be accepted into the trial."

Answered by AI

Are patients currently able to enroll in this ongoing medical study?

"Indeed, according to the information available on clinicaltrials.gov, this study is currently in the process of recruiting participants. The trial was initially posted on December 14th, 2023 and most recently updated on January 22nd, 2024. Researchers aim to recruit a total of 60 individuals from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation

2023. "The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06234930.

All > Alzheimers Disease New York